Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
International Pharmacopsychiatry|January 1, 1982
Systematic studies with amoxapine, a new antidepressantT A Ban, M Fujimori, W M Petrie, et al.
Pharmacotherapy|January 1, 1983
A double-blind clinical trial of mianserin versus amitriptyline: differentiation by adverse symptomatologyW Guy, J M McEvoy, T A Ban, et al.
International Pharmacopsychiatry|January 1, 1980
Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical studyW M Petrie, J P McEvoy, W H Wilson, et al.
International Pharmacopsychiatry|January 1, 1982
Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical studyW M Petrie, T A Ban, W H Wilson, et al.
Canadian Medical Association Journal|May 9, 1970
Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patientsR A Ramsay, T A Ban, H E Lehmann, et al.
Pharmacopsychiatria|May 1, 1982
Bromperidol maintenance in schizophreniaJ P McEvoy, W H Wilson, T A Ban, et al.
International Pharmacopsychiatry|January 1, 1980
Mianserin: determination of therapeutic dose rangeW M Petrie, W H Wilson, T A Ban, et al.
Clinical Therapeutics|January 1, 1987
Clozapine in the treatment of schizophrenic patients: an international multicenter trialG P Panteleeva, M Y Kovskaya, B S Belyaev, et al.
The Journal of Clinical Psychiatry|March 1, 1982
Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical studyJ P McEvoy, J Libiger, W H Wilson, et al.
Hospital & Community Psychiatry|December 1, 1986
A survey of psychiatrists' practices related to the use of tricyclic antidepressantsS C Goldberg, D H Tilley, R O Friedel, et al.
Pageof 8